You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

  1. Home
  2. Clinical Information
  3. Performance Measures
  4. Documentation of Signed Opioid Treatment Agreement

Documentation of Signed Opioid Treatment Agreement

    All patients 18 and older prescribed opiates for longer than six weeks duration who signed an opioid treatment agreement at least once during Opioid Therapy documented in the medical record.

    Date Reviewed: November 19, 2017
    Support
    Group/Practice Individual Clinician

    Measure Info

    MIPS 412CMS 412
    Measure Type: 
    Process
    Measure Steward: 
    American Academy of Neurology
    Clinical Topic Area: 
    Pain Assessment and Management
    Care Setting: 
    Outpatient
    Data Source: 
    Registry

    ACP supports QPP measure 412: "Documentation of Signed Opioid Treatment Agreement because it protects clinicians from the repercussions of patients who violate the opioid agreement. Also, considering the magnitude and urgency of the opioid epidemic, quality programs should adopt this measure unless data is otherwise available to describe the negative consequences of this measure. While we support this measure, we suggest the developers update the measure specifications to include appropriate exclusion criteria for patients receiving active cancer treatment, and patients receiving palliative and end-of-life care.